RP

Rajendrakumar Padmanabhan Kaimal

Active Director Director DIN 00032839
DIN 00032839 First appointment Jul 2003 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 10 active board seats
Past companies 9 historical roles
Total affiliations 19 Since Jul 2003
Shareholding value Locked Premium profile

About Rajendrakumar Padmanabhan Kaimal

Rajendrakumar Padmanabhan Kaimal has 23 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 10 companies, including Kobo Biotech Limited and Arch Agro Industries Private Limited. Formerly with 9 companies, such as Nipro Tube Glass Private Limited and Benzochem Lifesciences Private Limited. Engaged in Technology, General Business.

DIN 00032839
Primary Designation Director
First Appointment 29 Jul 2003
Oldest Company Age 33 yrs

Current companies

Company Designation Appointment Founded Status
Arch Agro Industries Private Limited U01403MH2011PTC218636
Director 14 Jun 2011 2011 Active
Amra Renal Care Limited U24100MH2011PLC223168
Director 17 Oct 2011 2011 Active
Arch Finechemicals Limited U24110TG1993PLC015533
Director 22 Aug 2007 1993 Active
Arch Pharmachem Ltd U24231MH2000PLC129882
Director 29 Jul 2003 2000 Active
Arch Herbals Private Limited U24233MH2000PTC126987
Additional Director 15 Feb 2013 2000 Active
Arch Life Sciences Limited U24239TG2003PLC042232
Director 02 Apr 2007 2003 Active
Vitalife Pharma Limited U24299MH2021PLC356633
Director 09 Mar 2021 2021 Active
Arch Impex Private Limited U51900MH2000PTC127806
Director 17 Sep 2003 2000 Active

Previous companies

Company Designation Appointment Founded Status
Nipro Tube Glass Private Limited U24100MH2000PTC125507
Director 31 Jul 2007 2000 Active
Benzochem Lifesciences Private Limited U24230MH2004PTC147388
Director 10 Jul 2008 2004 Active
Shriya Chemicals Pvt Ltd U24100MH1984PTC032849
Additional Director 19 Mar 2012 1984 Under Liquidation
Kobo Biotech Limited L24110TG1993PLC016112
Director 30 May 2013 1993 Under Cirp
Arch Pharmalabs Limited U24231MH1993PLC150891
Whole-Time Director 01 Nov 2003 1993 Under Cirp
Amra Remedies Limited U24239MH2011PLC213956
Director 23 Feb 2011 2011 Under Liquidation
Arch Infra Ventures Limited U45200MH2007PLC175780
Director 07 Nov 2007 2007 Strike Off
A M R Investments Private Limited U65190MH2007PTC171972
Director 25 Jun 2007 2007 Under Liquidation
Arch Investment Private Limited U65993MH1997PTC107197
Additional Director 15 Feb 2013 1997 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kobo Biotech Limited
Arch Agro Industries Private Limited
Amra Renal Care Limited
Arch Finechemicals Limited
Premium access

Shareholding and investment profile for Rajendrakumar Padmanabhan Kaimal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendrakumar Padmanabhan Kaimal

Rajendrakumar Padmanabhan Kaimal has 23 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 10 companies, including Kobo Biotech Limited and Arch Agro Industries Private Limited. Formerly with 9 companies, such as Nipro Tube Glass Private Limited and Benzochem Lifesciences Private Limited. Engaged in Technology, General Business.

Rajendrakumar Padmanabhan Kaimal is associated with 10 companies as Director and Whole-Time Director.

Rajendrakumar Padmanabhan Kaimal has expertise in Technology, General Business.

Rajendrakumar Padmanabhan Kaimal has 23 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available